GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (FRA:EJXB) » Definitions » COGS-to-Revenue

Elekta AB (FRA:EJXB) COGS-to-Revenue : 0.60 (As of Apr. 2025)


View and export this data going back to . Start your Free Trial

What is Elekta AB COGS-to-Revenue?

Elekta AB's Cost of Goods Sold for the three months ended in Apr. 2025 was €283 Mil. Its Revenue for the three months ended in Apr. 2025 was €470 Mil.

Elekta AB's COGS to Revenue for the three months ended in Apr. 2025 was 0.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Elekta AB's Gross Margin % for the three months ended in Apr. 2025 was 39.82%.


Elekta AB COGS-to-Revenue Historical Data

The historical data trend for Elekta AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB COGS-to-Revenue Chart

Elekta AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.63 0.62 0.63 0.63

Elekta AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.63 0.64 0.63 0.60

Elekta AB COGS-to-Revenue Calculation

Elekta AB's COGS to Revenue for the fiscal year that ended in Apr. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1026.811 / 1641.44
=0.63

Elekta AB's COGS to Revenue for the quarter that ended in Apr. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=282.715 / 469.764
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB  (FRA:EJXB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Elekta AB's Gross Margin % for the three months ended in Apr. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 282.715 / 469.764
=39.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Elekta AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Elekta AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 30%; Europe, the Middle East, and Africa accounting for 36%; and the Asia-Pacific contributing the remainder.

Elekta AB Headlines

No Headlines